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Abstract
Background
Plasmodium vivax causes the majority of malaria episodes outside Africa, but remains a
relatively understudied pathogen. The pathology of P. vivax infection depends critically on
the parasite’s ability to recognize and invade human erythrocytes. This invasion process
involves an interaction between P. vivax Duffy Binding Protein (PvDBP) in merozoites and
the Duffy antigen receptor for chemokines (DARC) on the erythrocyte surface. Whole-
genome sequencing of clinical isolates recently established that some P. vivax genomes
contain two copies of the PvDBP gene. The frequency of this duplication is particularly high
in Madagascar, where there is also evidence for P. vivax infection in DARC-negative indi-
viduals. The functional significance and global prevalence of this duplication, and whether
there are other copy number variations at the PvDBP locus, is unknown.
Methodology/Principal Findings
Using whole-genome sequencing and PCR to study the PvDBP locus in P. vivax clinical
isolates, we found that PvDBP duplication is widespread in Cambodia. The boundaries of
the Cambodian PvDBP duplication differ from those previously identified in Madagascar,
meaning that current molecular assays were unable to detect it. The Cambodian PvDBP
duplication did not associate with parasite density or DARC genotype, and ranged in
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prevalence from 20% to 38% over four annual transmission seasons in Cambodia. This
duplication was also present in P. vivax isolates from Brazil and Ethiopia, but not India.
Conclusions/Significance
PvDBP duplications are much more widespread and complex than previously thought, and
at least two distinct duplications are circulating globally. The same duplication boundaries
were identified in parasites from three continents, and were found at high prevalence in
human populations where DARC-negativity is essentially absent. It is therefore unlikely that
PvDBP duplication is associated with infection of DARC-negative individuals, but functional
tests will be required to confirm this hypothesis.
Author Summary
Malaria parasites must be adaptable to evade the human immune system and successfully
transmit themselves to different individuals. Key to this adaptability is the fact that malaria
parasite genomes are highly variable, containing mutations ranging from simple small
changes in DNA sequence to complex large-scale changes in the number of copies of indi-
vidual genes. Some samples of Plasmodium vivax, the parasite that causes most malaria
episodes outside Africa, have recently been found to have duplicated the gene encoding
Duffy Binding Protein, which enables P. vivax parasites to recognize and invade human
red blood cells. By studying parasites from Cambodian patients with P. vivaxmalaria, we
have discovered that there are actually two different types of gene duplication, with the
new duplication type identified in this study present in 20% to 38% of Cambodian P. vivax
isolates tested. The same gene duplication was also found in parasites from Brazilian and
Ethiopian patients with P. vivaxmalaria, suggesting that variation in this gene is more
complex and common than previously thought. The functional significance and origin of
these two gene duplications requires further study.
Introduction
Plasmodium parasites must recognize and invade erythrocytes to multiply and cause clinical
disease in humans. Erythrocyte invasion is a complex multi-step process involving multiple
protein-protein interactions between the extracellular Plasmodium merozoite and its target
erythrocyte.While P. falciparum merozoite proteins have some overlapping and partially
redundant interactions with several different erythrocyte receptors [1], P. vivaxmerozoites
appear to rely heavily on the interaction between P. vivaxDuffy Binding Protein (PvDBP) and
the erythrocyteDuffy antigen receptor for chemokines (DARC) to invade human erythrocytes
[2–4]. There are numerous common genetic variants at theDARC locus, including the DARC-
negative or FYBES/BES genotype, where a polymorphism in theDARC promoter eliminates
expression of DARC specifically in erythroid cells, producing an Fy(a-b-) phenotype [5].
DARC-negativity is nearly ubiquitous inWest and Central Africa and, given that erythrocyte
invasion is essential for parasite survival, is associated with protection against P. vivax infection
[6]. PvDBP is therefore a high-priority P. vivax vaccine candidate [7]. The essentiality of the
PvDBP-DARC interaction for P. vivax invasion has recently been challenged by the discovery
of confirmedP. vivax infections in DARC-negative individuals in Madagascar [8], a finding
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that is consistent with several independent reports of P. vivax infections in DARC-negative
individuals inWest and Central Africa [9]. The molecular basis of P. vivax invasion into
DARC-negative erythrocytes is currently unknown, although it may still involve PvDBP.
Given this focus on PvDBP for both vaccine and biological studies, understanding the extent
and functional consequences of PvDBP variation is important. Previous attention to PvDBP
variation has focused on single-nucleotide polymorphisms (SNPs), which are common and
appear to result in strain-specific immune responses [10,11]. Recent whole-genome sequencing
of a P. vivax strain fromMadagascar identified another source of variation, namely duplication
of the entire PvDBP locus [12]. A simple PCR assay based on these whole-genome sequence
data revealed that PvDBP duplication was present in more than half of Malagasy P. vivax sam-
ples, and in much lower proportions of East African, Asian, and South American samples. This
finding has since been confirmed by whole-genome sequencing of>200 P. vivax isolates from
around the world, where evidence for duplication based on increased sequence coverage was
found in 35% of Cambodian isolates [13].
The functional consequences of PvDBP duplication are unknown, although its high preva-
lence inMadagascar raised the intriguing possibility that it is somehow associated with success-
ful P. vivax infection of DARC-negative individuals.Whether the PvDBP duplication arose
only once and spread globally, or arose independently more than once, which would suggest
localized selection pressure, is also unknown.While such locally-selectedcopy number varia-
tions (CNVs) in Plasmodium genes are known to associate with drug resistance, such as CNVs
at the PfMDR1 locus in association with mefloquine resistance [14,15], such CNV selection has
not yet been associated with genes involved in fundamental biological processes such as eryth-
rocyte invasion. To address the origins of CNVs at the PvDBP locus, we investigated the preva-
lence and nature of PvDBP duplications in 37 P. vivax samples collected in a clinical study of
human genetic resistance to P. vivaxmalaria in Cambodia [16], which were subsequently
sequenced by the Malaria Programme at theWellcome Trust Sanger Institute (WTSI) as part
of a larger study [13]. This identified a new type of duplication, which was then validated in
>350 samples from all three continents where P. vivax infections are found.
Methods
Patient samples and ethics statement
Cambodia:During each annual malaria season (June-December) from 2008 to 2011, patients
presenting with malaria symptoms were screened at Sampov Meas Referral Hospital in Pursat.
A total of 898 patients were diagnosedwith P. vivaxmalaria and participated in a study of
human genetic resistance to this disease. The clinical protocol was approved by the National
Ethics Committee for Health Research in Cambodia and the NIAID Institutional Review
Board in the United States (ClinicalTrials.gov identifier NCT00663546). Following written
informed consent, patients provided a venous blood sample, and DNA was extracted from
200 μl of whole blood using a QiaAmp kit (Qiagen, USA). Of these samples, 49–50 samples per
year were randomly selected for analysis.
Ethiopia: During the peakmalaria season (September-November) in 2014, patients present-
ing with malaria symptoms were screened at health centers in Jimma. Finger-prick blood sam-
ples (50 μl) were collected and screened for P. vivax infection by both microscopy and nested
PCR. A total of 25 patients were diagnosedwith P. vivaxmalaria and provided written
informed consent to participate in this study. The clinical protocol was approved by the institu-
tional review boards of Jimma University in Ethiopia and University of California, Irvine in the
United States.
Plasmodium vivax Duffy Binding Protein Gene Duplications
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India: From July 2013 to December 2015, patients presenting with malaria symptoms were
screened at GoaMedical College by both rapid diagnostic test (RDT) and microscopy. Patients
with P. vivaxmonoinfectionwere then referred to the Malaria Evolution in South Asia
(MESA) International Center for Excellence inMalaria Research (ICEMR) study team.Written
informed consent was obtained from adult patients and the parents or guardians of minors;
verbal assent was provided by children aged 8–17 years. Subjects provided 4–6 ml of venous
blood, and parasite species was confirmed by RDT (FalciVax, Zephyr Biomedicals, India) and
microscopy. A random selection of 72 P. vivaxmonoinfections (from a total of 838 P. vivax
monoinfections diagnosed during the study period)was tested for the presence of PvDBP
duplication. DNA was extracted from 50–500 μl of whole blood using a QiaAmp kit (Qiagen,
USA). The clinical protocol was approved by the institutional review boards of GoaMedical
College and Hospital, University of Washington, NIAID Division of Microbiology and Infec-
tious Diseases, and Government of India Health Ministry ScreeningCommittee.
Brazil: From 2008 to 2011, patients presenting with malaria symptoms at clinics in Acrelân-
dia and Plácido de Castro [17] were screened by microscopy. Patients with Plasmodium infec-
tion provided 15-ml venous blood samples that were further examined for malaria parasites by
a quantitative real-time PCR specific for the 18S rRNA gene. Written informed consent was
obtained from adult patients and the parents or guardians of minors. A random selection of six
P. vivaxmonoinfections was tested for the presence of PvDBP duplication. These samples were
collected under protocols approved by the Institutional ReviewBoard of the Institute of Bio-
medical Sciences, University of São Paulo, Brazil (936/CEP, 2010).
Brazil: From June 2014 to September 2015, patients aged 5–63 years presenting with malaria
symptoms at clinics in the urban area of Mâncio Lima were screened by microscopy. Patients
positive for P. vivax infectionwere enrolled in a clinical trial of P. vivax response to chloro-
quine alone vs. chloroquine plus primaquine (ClinicalTrials.gov Identifier: NCT02691910) and
provided 40-ml venous blood samples. Written informed consent was obtained from adult
patients and the parents or guardians of minors. A random selection of 54 P. vivaxmonoinfec-
tions was tested for the presence of PvDBP duplication. These samples were collected under
protocols approved by the Institutional ReviewBoard of the Institute of Biomedical Sciences,
University of São Paulo, Brazil (1169/CEP, 2014).
A random selection of samples were tested from Cambodia, Ethiopia, India and Brazil, with
numbers based on sample availability.
Identification of a novel PvDBP duplication in Cambodian P. vivax
isolates
A subset of 37 Cambodian patients with P. vivaxmalaria provided an 8-ml blood sample,
which was depleted of leukocytes using CF11 prior to DNA extraction [18]. These samples
were sequenced at theWTSI using Illumina sequencing technology, as described [13]. As part
of the genome analyses, the generated sequences were mapped individually to the P. vivax Sal1
reference genome (http://plasmodb.org/common/downloads/release-10.0/PvivaxSal1/fasta/
data/PlasmoDB-10.0_PvivaxSal1_Genome.fasta) [19] using bwa version 0.5.9-r16 with
default parameters [20]. In the present study, the resulting assembly bam files were reviewed
in the region containing PvDBP (chromosome 6: 976329–980090, GenBank accession
ID = PVX_110810) using the Artemis genome viewer [21] or Lookseq [22]. Mate pairs that
were oriented tail-to-tail, and thus signified that PvDBPwas duplicated, were visualized in
either Artemis using a “non-proper pair” read filter or Looksequsing the “face-away” setting.
To compare the breakpoints in Cambodian and Malagasy isolates, the read data for the Mala-
gasy P. vivaxM15 isolate (with a duplicated PvDBP) (SRA accession SRX266275) were mapped
Plasmodium vivax Duffy Binding Protein Gene Duplications
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to the reference P. vivax Sal1 genome using bowtie2 v2.1.0 [23] with default parameters, except
for counting overlapping reads as concordant pairs (--dovetail). In all sequences the PvDBP
genes were reviewed for evidence of intra-isolate SNPs with a frequency of 0.3–0.7 and a mini-
mum read coverage of 5 for both reference and alternative alleles using all SNPs called using
GATK’s Haplotype caller with default settings [24,25]. Average coverage across all 14 reference
P. vivax Sal1 chromosomes and the PvDBP locus (chromosome 6: 976329 to 980090) was com-
puted using GATK’s DepthOfCoverage tool and compared to estimate PvDBP amplification
[24,25].
PvDBP duplication-specific PCR assay
We used previously-published primers and new primers to identify PvDBP duplications in our
samples. Previously-published primers fromMenard et al. [12] are as follows: primer pair 5’-
CCATAAAAGGTAGGAAAT TGGAAA-3’ (AF) and 5’-GCATTTTATGAAAACGGTGCT-3’
(AR), which amplifies a 613-bp region surrounding the Malagasy isolates’ breakpoint at posi-
tion 982947, and primer pair 5’-TCATCGAGCATGTTCCTTTG-3’(BF) and 5’-TTGCACG-
TACTCGAAACTCAG-3’ (BR), which amplifies a 643-bp region surrounding the breakpoint
at position 974770. BF+AR are predicted to amplify a 612-bp product that contains the junc-
tion between the PvDBP copies in isolates with duplications matching those in Malagasy iso-
lates (based on GenBank accession ID KF159580). BF+BR are predicted to amplify the
identical breakpoint in Cambodian isolates. Primer pair 5’-ACGCGATGTATCTTCTTTTCA-
3’ (AF2) and 5’-TAGAACGCACAGTTATTGGC -3’ (AR2) are designed to amplify a 657-bp
region surrounding the breakpoint at position 982100 in Cambodian samples. AF2+AR2 are
expected to amplify the region in samples with or without the PvDBP duplication and were
used as positive controls. In samples with the CambodianPvDBP duplication, BF+AR2 are
expected to amplify a 736-bp product that contains the junction between the PvDBP copies.
In Malagasy samples, BF+AR2 are expected to amplify a 1584-bp product containing the
PvDBP duplication. These primers are opposite-facing in samples without the duplication
and thus are not expected to produce a product. Duplication PCR products were capillary
sequenced, and chromatograms were reviewed to determine the exact breakpoint. PCR reac-
tion volumes contained 20 μl Platinum PCR Supermix (Thermo Fisher Scientific,USA), 1 μl
DNA template, and 0.5 μl each primer (10 μM working stocks). PCR conditions were: 94°C for
2 min, followed by 35 cycles of 94°C for 20 s, 55°C for 30 s, and 68°C for 60 s, followed by a
4-min extension.
Duffy genotype PCR assay
To genotype the Duffy blood group (Fy), we used the following published primers (see SI
Appendix C in [8]): primer pair 5’-GTGGGGTAAGGCTTCCTGAT-3’ (Fy-F) and 5’-
CAGAGCTGCGAGTGCTACCT-3’ (Fy-R), which amplifies a 1100-bp region spanning the
GATA-1 transcription factor-binding site that determines DARC expression on erythrocytes
[FYB versus FYBES in the promotor region of PvDBP (-33, TTATCT for wild-type versus
TTACCT for erythrocyte silent FYBES/FYBES)] through the exon-two SNPs determining
FYA versus FYB genotypes [codon 42, GGT (G) for FYA versus GAT (D) for FYB] and the
FYBweak genotype (codon 89, CGC (R) for FYB versus TGC (C) for FYBweak). The FYBweak
genotype is only known to be associated with the FYB genotype. PCR reaction volumes con-
tained 20 μl Platinum PCR Supermix, 1 μl DNA template, and 0.5 μl each primer (10 μM work-
ing stocks). PCR conditions were: 94°C for 2 min, followed by 35 cycles of 94°C for 20 s,
58°C for 30 s, and 68°C for 60 s, followed by a 4-min extension. PCR products were capillary
sequenced using the following four published primers: 5’- GTGGGGTAAGGCTTCCTGAT-3’
Plasmodium vivax Duffy Binding Protein Gene Duplications
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(Fy-F), 5’- CAAACAGCAGGGGAAATGAG-3’ (GATA-1-R), 5’-CTTCCGGTGTAACTCT
GATGG-3’ (Exon2-F), and 5’- CAGAGCTGCGAGTGCTACCT-3’ (Fy-R) (see SI Appendix C
in [8]). Sequences were aligned to a reference sequence for DARC (GenBank accession number
S76830.1, http://www.ncbi.nlm.nih.gov/nuccore/S76830.1), and chromatograms were visually
inspected to determine FY genotypes.We determined the sequence at all three SNP sites in 129
samples, and at only the FYA and FYB sites in another 33 samples.
PvDBP haplotypes and phylogeny
PvDBP haplotypes of the most abundant clone in each of 37 whole-genome-sequencedCambo-
dian samples and one Malagasy P. vivaxM15 sample were reconstructed using GATK’s Haplo-
typeCaller v 3.4 [24,25], setting “sample ploidy” to 1 for the PvDBP locus (chromosome 6:
976329 to 980090). The resulting vcf file was used with GATK’s FastaAlternateReferenceMaker
to construct FASTA files representing one PvDBP gene in each sample. The haplotype of the
PvDBP region for P. vivaxM15 was identical to the sequence deposited in GenBank (accession
ID = KF159580), except for calling the majority “T” at position 50 instead of using the IUPAC
code “Y,” representing the C/T polymorphic site. PvDBP sequences of all 37 Cambodian sam-
ples, Malagasy isolate P. vivaxM15, and P. vivax Sal1 were alignedwith ClustalW [26] based
on default settings followed by manual editing in SequenceAlignment Editor v1.d1 [27]. Hap-
lotype diversity was assessed using DnaSP v5.10.1 [28] with default settings. A phylogenetic
tree was reconstructed using the maximum likelihoodmethod implemented in RAxML [29]
with 500 bootstrap replicates to assess clade support.
Results
A new type of PvDBP duplication is present in Cambodian isolates
Initial attempts to detect PvDBP duplications in CambodianP. vivax samples using previously-
published PCR primers [12] failed repeatedly (example shown in Fig 1C). To establish whether
this was due to technical issues or the absence of PvDBP duplications in Cambodian P. vivax
isolates, we used bwa [20] to map previously-generated Illumina sequence reads from individ-
ual Cambodian P. vivax isolates to the Sal1 reference genome [13]. Visual inspection of the
alignments in Artemis [21] and LookSeq [22] clearly showed increased sequence coverage at
the PvDBP locus in some isolates, including some where PCR-based detection had failed. Iso-
late PV0431 showed increased sequence coverage at the PvDBP gene region compared to flank-
ing regions (Fig 1A, upper panel, blue trace), while isolate PV0430 showed even sequence
coverage over these same regions (black trace). A PvDBP duplication was confirmed by identi-
fying paired-end reads that mapped in the tail-to-tail, instead of the expected head-to-head,
orientation (Fig 1A, middle panel, blue trace). To investigate whether this duplication was
identical to the one previously identified in a Malagasy isolate [12], we mapped tail-to-tail
reads for the Malagasy M15 isolate in the same manner (Fig 1A, middle panel, red trace).
While the 5’ boundary of the duplication was identical in both genomes, the 3’ boundarywas
not, indicating that the tandemly-duplicated PvDBP region in Cambodian isolate PV0431 is
shorter than that previously observed inMalagasy P. vivax isolates. Importantly, one of the pre-
viously-published PCR primers (AR) used to detect PvDBP duplication in Malagasy samples
maps to the region that is not duplicated in these genomes, explaining how this primer failed to
detect PvDBP duplication in Cambodian samples.
To investigate how widespread this new duplication is, we designed and tested new primers
to amplify the alternative 3’ breakpoint observed in Cambodian isolate PV0431, hereafter
referred to as the Cambodian, as opposed to the Malagasy, duplication (Fig 1B). We tested
both new (AR2) and old (AR) 3’ primers on two Cambodian isolates that sequencing had
Plasmodium vivax Duffy Binding Protein Gene Duplications
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identified as carrying (PV0431) or lacking (PV0430) a PvDBP duplication. As expected, the old
BF+AR primers that detect the Malagasy duplication did not amplify a PCR product from
PV0431, whereas the new BF+AR2 primers that detect the Cambodian duplication did amplify
a PCR product of the expected size (Fig 1C). We detected no duplication in PV0430, which
Illumina sequencing confirmed lacked a PvDBP duplication, and control primers confirmed
that the regions flanking the PvDBP gene were present in both isolates. Importantly, the new
BF+AR2 primers are able to amplify bothMalagasy and Cambodian types of PvDBP duplica-
tion, but yield differentially-sizedproducts.
These primers were then used to confirm the presence or absence of PvDBP duplication in
all 35 whole-genome-sequencedCambodian samples for which DNA was still available
(Table 1). Identically-sized PCR products validated the Cambodian-typePvDBP duplication
for 14/35 isolates tested, 11/11 of which contained both elevated coverage and the presence of
tail-to-tail reads (no DNA remained for a 12th sample with both elevated coverage and tail-to-
tail reads). Duplication of PvDBPwas supported in 2/3 additional isolates (PH0180-C,
PH1113-C, PH1116-C) which lacked elevated coverage of PvDBP (1.17–1.38x) but did contain
both tail-to-tail reads and intra-isolate SNPs. This suggests the presence of minor clones with
the PvDBP duplication in these isolates, for which the limit of detectionwas reached in the case
of PH0180-C. One additional isolate (PH0177-C), which lacked both tail-to-tail mates and ele-
vated coverage of PvDBP, showed the PvDBP duplication by PCR. This may represent an addi-
tional minor clone not detected by whole-genome sequencing. Taken together, these results
suggest that increased coverage, while least sensitive, is a usefulmarker for PvDBP duplications
in this dataset. The presence of tail-to-tail read pairs and/or duplication-detecting PCRs, while
not in complete agreement, have greater sensitivity and are likely both better able to detect
PvDBP duplications in minor clones.
Genetic diversity in PvDBP sequences
For the 12 isolates with PvDBP duplication supported by 1.8–2.8x coverage of PvDBP com-
pared to average coverage of the entire genome, we reviewed intra-isolate SNPs in PvDBP to
determine whether the two gene copies in a given isolate were identical. In 10 of the 12 isolates,
there were no SNPs between the two PvDBP copies. In the other two isolates (PH1133-C,
PH0182-C), there were SNPs at 30% and 70% frequency between the two PvDBP copies
(Table 1), as well as SNPs at 30–70% frequency throughout the genome. These data suggest
that these are polyclonal isolates, rather than clonal isolates containing two sequence-divergent
PvDBP copies.
We aligned the PvDBPDNA sequences (including introns) of the reference P. vivax Sal1
line, Malagasy P. vivaxM15 isolate, and all 37 whole-genome-sequencedCambodian P. vivax
isolates (including only the dominant haplotype when SNPs were present). Out of 3804 aligned
bases, 51 sites were polymorphic (1.3%), excluding indels; we found unique PvDBP haplotypes
in 77% (30/39) of samples, with a haplotype diversity of 0.98 ± 0.01. We categorized isolates as
having either one or two PvDBP copies, excluding PH0177-C, PH0180-C, PH1113-C, and
Fig 1. PvDBP duplication in Cambodian isolates. (A) Artemis genome view [21] showing whole-genome sequence coverage in the PvDBP
region of PV0431 (blue trace) and PV0430 (black trace) for all reads (upper panel) and non-proper paired reads (middle panel). The Malagasy P.
vivax M15 isolate’s non-proper paired reads (red trace, middle panel) suggest that its PvDBP duplication length is longer than that of PV0431. (B)
Schematic of the PvDBP region and primer-binding locations in samples with a single PvDBP gene (top), a Malagasy PvDBP duplication region
(middle), and a shorter Cambodian PvDBP duplication region (bottom). AR2+BF primers amplify both Malagasy and Cambodian breakpoints
spanning the duplicated regions, while AR+BF primers only amplify Malagasy breakpoints. (C) Cambodian isolate PV0431 with a duplicated
PvDBP region and PV0430 with a single PvDBP region, as determined by whole-genome sequencing. BF+AR primers failed to amplify the
Malagasy PvDBP duplication in both Cambodian samples, while BF+AR2 primers successfully amplified the Cambodian PvDBP duplication in
PV0431. AF2+AR2 primers detected PvDBP duplications in both Cambodian isolates, but not in DNA-negative controls (-).
doi:10.1371/journal.pntd.0005091.g001
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PH1116-C, which contained tail-to-tail read pairs and/or PCR support for duplication, but no
increase in regional coverage. In a maximum likelihood tree analysis, isolates with either one or
two PvDBP copies were intermixed and did not form distinct clades (Fig 2). This suggests that
Table 1. Cambodian isolates with single and duplicated copies of PvDBP.
PvDBP status WTSI ID NIH ID Average genome
coverage
Average PvDBP
coverage
PvDBP
copy #
Tail-to-tail
mate pairs (Y)
PCR supports PvDBP
dup. (N/Y) †
Intra-isolate
SNPs***
Single PvDBP* PH0067-C 11.67 12.75 1.09 N 0
PH0068-C 8.64 11.66 1.35 N 0
PH0075-C 6.92 9.15 1.32 N 0
PH0086-C 7.68 8.51 1.11 N 0
PH0089-C 10.33 13.47 1.3 N 0
PH0098-C 7.64 7.67 1 N 0
PH0177-C 177.36 160.49 0.9 Y 0
PH0180-C 57.69 70.6 1.22 Y N 10
PH0187-C 93.72 120.48 1.29 N 7
PH0189-C PV0430 113.45 123.58 1.09 N 0
PH0310-C 71.63 74.04 1.03 N 0
PH0320-C 94.67 79.45 0.84 N 0
PH0385-C 35.84 43.12 1.2 N 0
PH1078-C 13.94 13.72 0.98 na 0
PH1109-C 50.66 50.44 1 N 0
PH1111-C 5.3 6.67 1.26 N 0
PH1112-C 17.18 19.25 1.12 N 0
PH1113-C 18.58 21.75 1.17 Y Y 2
PH1116-C 11.98 16.52 1.38 Y Y 15
PH1117-C 5.78 6.58 1.14 N 0
PH1121-C 10.29 12.16 1.18 N 0
PH1124-C 18.06 17.8 0.99 N 0
PH1126-C 10.9 9.95 0.91 N 6
PH1131-C 7.25 8.87 1.22 N 0
PH1132-C 6.26 6.82 1.09 N 0
Duplicated
PvDBP**
PH0178-C 82.52 183.31 2.22 Y Y 0
PH0184-C 47.65 111.6 2.34 Y Y 0
PH0188-C 176.17 372.57 2.11 Y Y 0
PH0190-C PV0431 152.9 427.71 2.8 Y Y 0
PH0309-C 21.37 49 2.29 Y Y 0
PH0182-C 25.68 46.37 1.81 Y Y 28
PH1084-C 6.89 15.06 2.19 Y na 0
PH1115-C 11.22 25.6 2.28 Y Y 0
PH1119-C 10.46 21.32 2.04 Y Y 0
PH1125-C 14.92 28.86 1.93 Y Y 0
PH1133-C 15.07 34.33 2.28 Y Y 6
PH1135-C 6.42 13.77 2.14 Y Y 0
*Coverage of PvDBP 0.8–1.4x
**Coverage of PvDBP 1.8–2.8x
***Minimum of 5 reads supporting reference and alternative allele; allele frequencies 0.3–0.7
†All PCR results support only the shorter Cambodian PvDBP duplication
na, No remaining DNA available
doi:10.1371/journal.pntd.0005091.t001
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Fig 2. Maximum likelihood tree for PvDBP sequences in Cambodia. Maximum likelihood tree reconstructed based on alignment by ClustalW with
bootstrap analyses to assess clade support (500 replicates) using a single consensus sequence for PvDBP (including introns) for 33 Cambodian
isolates with PvDBP duplications (red) or single copies of PvDBP (blue) with numbers corresponding to the WTSI ID numbers in Table 1. Duplications
were predicted by 1.8–2.8x average coverage in PvDBP compared to genome-wide average coverage, the presence of tail-to-tail mate pairs and PCR
results (Table 1). P. vivax Sal1 containing one PvDBP gene (magenta) and Malagasy P. vivax M15 containing two PvDBP genes (green) are included
as references. *bootstrap values >85%.
doi:10.1371/journal.pntd.0005091.g002
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PvDBP duplication in Cambodian parasites is not the result of a single duplication event that
has spread throughout the population.We found only three clades with bootstrap values
>0.85, indicating that there are too few SNPs shared overall (likely due to outbreeding) to sup-
port the phylogenetic relationships between samples.
Prevalence of PvDBP duplication in Cambodia, and its association with
parasitemia and DARC genotype
We used the new BF+AR2 primers to measure the prevalence of PvDBP duplications in 198
Cambodian P. vivax isolates collected over four years in this seasonal transmission setting.
None of these samples had been previously studied for PvDBP duplication by whole-genome
sequencing or any other method. Overall, 29% (57/198) of P. vivax samples contained the
duplication, with an annual prevalence ranging from 20% to 38% (Fig 3A). PCR product sizes
suggested that all samples contained the Cambodian but not the Malagasy PvDBP duplication.
This was confirmed by capillary sequencing of PCR products in 43 isolates with the duplica-
tion; in all cases, the duplication breakpoints occurred at an identical poly-T region marking
the boundary of the Cambodian PvDBP duplication (linker sequence in S1 Fig). The 29% prev-
alence of PvDBP duplication in 198 Cambodian samples, as measured using the new BF+AR2
primers, is similar to the 32% (6/19) prevalence previously measured by whole-genome
sequencing of a much smaller number of Cambodian isolates, although as noted this analysis
only scored the presence of the duplication, not its precise boundary [13].
To assess whether PvDBP duplication is associated with higher parasite densities (which
might suggest increased invasion efficiency) in Cambodian patients with malaria, we stratified
parasite densities according to PvDBP copy number across these 198 newly-genotyped isolates.
Parasite densities were not significantly different between parasites carrying one or two PvDBP
genes (Fig 3B). There is no reportedDARC-negativity in Cambodia,making it unlikely that the
high prevalence of PvDBP duplication is associated with invasion into DARC-negative erythro-
cytes in this country. However, differentDARC genotypes are present, and it has been recently
found that susceptibility to P. vivaxmalaria episodes is higher in the FYB/FYB genotype rela-
tive to the FYA/FYA genotype, possibly due to significantly reduced binding of PvDBP to Fy
(a+b-) erythrocytes [30,31]. To establish whether there is any association between FYA or
FYB genotypes and PvDBP duplication in Cambodia,we sequenced theDARC genotypes of
159 patient samples that were also genotyped for PvDBP duplications. As shown in Fig 3C,
73% (116/159) of patients were FYA homozygotes and 26% (42/159) were FYA/B heterozy-
gotes. A single patient (1/159) was homozygous for FYB. As expected,we found no evidence
for the DARC-negative FYBES allele in these 159 samples. Neither FYA nor FYA/B were
significantly associated with PvDBP duplications in this study population (Fig 3D).
Global distribution of Cambodian and Malagasy PvDBP duplications
To determine whether the Cambodian PvDBP duplication is present outside Cambodia, we
used the new BF+AR2 primers to amplify the PvDBP region in P. vivax clinical isolates, none
of which had been previously analysed for PvDBP duplication, from three different continents.
While we did not detect Cambodian or Malagasy PvDBP duplications in 72 samples from Goa,
India (Fig 4B), we found Cambodian PvDBP duplications in 10% (6/60) of samples from Brazil
(Fig 4A) and 56% (14/25) of samples from Ethiopia (Fig 4C). Interestingly, Malagasy duplica-
tions were also found in samples from Ethiopia (Fig 4C) but not Brazil (Fig 4A). These data,
combined with those previously published for the Malagasy PvDBP duplication [12], indicate
that both types of PvDBP duplication are globally distributed (Fig 4D).
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Discussion
Although P. vivax causes the majority of malaria cases in Asia, South America, and the Pacific,
research of the P. vivax genome lags significantly behind that of the P. falciparum genome.
While thousands of P. falciparum clinical isolates have already been sequenced and analyzed,
revealing insights into global epidemiology, as well as the origin and spread of drug resistance
[32–34], only a handful of P. vivax genome sequences were publicly available until recently.
Genomic data from four isolates suggested that P. vivax diversity may be more extensive than
Fig 3. Prevalence of PvDBP duplication in Cambodia, and its association with parasite density and DARC genotypes. (A) The proportion of
parasites carrying a PvDBP duplication (detected by PCR) over four years is shown. (B-D) P. vivax densities were not significantly different when
stratified by (B) PvDBP copy number, (C) DARC genotype, or (D) combinations of PvDBP copy number and DARC genotype (Mann-Whitney test,
P>0.05). Median (interquartile range, IQR) parasite densities are shown. ns, not significant. P values for 3D are reported in S1 Table.
doi:10.1371/journal.pntd.0005091.g003
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Fig 4. Global distribution of Cambodian and Malagasy PvDBP duplications. PCR primers that detect Cambodian and Malagasy
PvDBP duplications were tested in three P. vivax-endemic countries (Brazil, India, Ethiopia). (A) Brazilian isolates 1 and 2 contain a
Cambodian PvDBP duplication and a single PvDBP region, respectively. Note that the sizes (and sequences, S1 Fig) of the PCR products
match the Cambodian PvDBP duplication detected by the BF+AR2 primers, but not the Malagasy PvDBP duplication detected by the BF
+AR primers. (B) Indian isolates 1 and 2 lack Cambodian and Malagasy PvDBP duplications. (C) Ethiopian isolates 1, 2, and 3 contain a
Malagasy PvDBP duplication, a Cambodian PvDBP duplication, and a single PvDBP region, respectively. (A-C) All isolates show bands for
the positive control AF2+AR2 primers, and no bands for DNA-negative controls (-). (D) In the present study, the prevalence of Cambodian
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P. falciparum diversity [35], and sequencing additional isolates fromMadagascar and Cambo-
dia revealed CNVs and indels in genes associated with erythrocyte invasion [12,36], including
a PvDBP gene duplication. Given the number of samples in these studies, however, it was not
possible to infer whether any of these features are confined to individual infections or geo-
graphic locations, or are much more widespread and common forms of variation. The recent
publication of more than 200 P. vivax genomes from across the world revealed that CNV at the
PvDBP locus is one of the most common CNVs in the P. vivax genome [13]. In contrast, no
PvDBP duplications were found in a concurrent population genomics study of 182 P. vivax iso-
lates from 11 endemic countries [37]. This discrepancymay be due in large part to the reliance
on the Malagasy duplication primers for validation in the latter study, which as noted here will
miss the newly-identifiedCambodian duplication [37]. In this study, we used sequence data
from clinical isolates [13] to infer that PvDBP duplications in Cambodia had different bound-
aries than the PvDBP duplication in Madagascar [12]. Using these sequence data to define new
duplication-specific PCR primers, we defined the boundaries of this new duplication type,
showed that it was present at a prevalence between 20% and 38% over four consecutive trans-
mission seasons in Cambodia, and that it was also present in P. vivax infections in Ethiopia
and Brazil, although absent from a study site in India. In Cambodia, there was no association
betweenPvDBP duplication and either parasite burden or DARC genotype. Thus, there are at
least two common forms of PvDBP duplication with global distribution; the duplication-spe-
cific PCR primers defined in this study will help to estimate their prevalence in other P. vivax-
endemic regions and enable genotype-phenotype correlation studies.
One key question is whether the Cambodian and Malagasy duplications arose indepen-
dently in specific locations and then spread around the world, or whether PvDBPCNVs are
continuously arising de novo, but consistently occur at the same defined boundaries, leading to
either “Malagasy-type” or “Cambodia-type” PvDBP duplications. Phylogenetic analysis at this
stage favors the latter hypothesis. PvDBP is known to be under positive selection pressure [38],
with widespread diversity even within the DARC-binding region, Domain II. Of the 12 Cam-
bodian isolates that have been whole-genome sequenced and have PvDBP duplications, ten
have duplicated PvDBP genes that are identical in sequence. In phylogenetic trees, these
sequences are interspersed with PvDBP sequences from samples without duplications, strongly
suggesting that the Cambodian duplication arose independentlymultiple times on different
genetic backgrounds. An alternative explanation is that the Cambodian duplication arose only
once, and the two PvDBP genes subsequently diverged due to immune selection pressure.
Under this hypothesis, frequent gene conversion would be required to maintain sequence iden-
tity between the two PvDBP copies within a given isolate. Whether this is likely is unclear, as
little is known about the frequency of gene conversion in Plasmodium parasites, although this
phenomenon of shared mutations between identical adjacent regions of the genome has previ-
ously been seen in other invasion genes in P. falciparum [39]. At this moment, however, inde-
pendent origins of PvDBP duplication at defined amplification hotspots appears to be the
simplest explanation.
The nature of the PvDBP duplication boundaries also favors this hypothesis and hints at a
potential molecularmechanism.While there is no homology between the 3’ boundaries of the
Cambodian and Malagasy duplications, both occur in homopolymeric T tracks, which are not
as frequent in the P. vivax genome as they are in the AT-rich P. falciparum genome. Recent in
PvDBP duplication is 0/72 in India, 6/60 in Brazil, 14/25 in Ethiopia, and 57/198 in Cambodia, and the prevalence of Malagasy PvDBP
duplication is 0/72 in India, 0/60 in Brazil, 2/25 in Ethiopia, and 0/198 in Cambodia. In a previous study [12], the prevalence of Malagasy
PvDBP duplication was 4/32 in Sudan, 100/189 in Madagascar, and 3/33 in Cambodia.
doi:10.1371/journal.pntd.0005091.g004
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vitro studies selecting for P. falciparum parasites with resistance to DSM1, an inhibitor of dihy-
droorotate dehydrogenase (DHODH), producedmultiple lines with CNVs at the PfDHODH
locus [40]. These CNVs had different boundaries, but notably all of them contained homopoly-
meric A or T tracks, suggesting that such tracks facilitate frequent localized recombination and
CNV generation during DNA replication. Such CNVs may provide raw material for evolution,
by providing a second copy of a given gene or enabling the accumulation of mutations in one
copy while limiting the potential risk of deleteriousmutations by maintaining a second wild-
type copy. In Plasmodium parasites, which are faced with numerous strong selection pressures
in both humans and mosquitoes, the advantages of such a mechanism are obvious. While it is
not known whether this mechanism is common, the parallels betweenPfDHODH and PvDBP
CNVs are intriguing, and a genome-wide analysis of common CNVs could be revealing.
What then is driving CNVs at the PvDBP locus? The best known examples of CNVs at Plas-
modium genes involve antimalarial drug resistance; for example, selection pressure frommef-
loquine amplifies theMDR1 gene in P. falciparum [41] and perhaps also in P. vivax [13].
Antimalarial drug pressure appears unlikely in this context, although not inconceivable; for
example, if PvDBP duplication confers an increased growth rate to P. vivax parasites, this could
provide an advantage against some slow-acting drugs. However, given the critical role of the
PvDBP-DARC interaction in P. vivax erythrocyte invasion, it is likely that CNVs at PvDBP are
being selected by genetic variation inDARC. Is this variation DARC-negativity? The presence
of PvDBP duplications at frequencies approaching 40% both globally [12,13], and over multiple
transmission seasons in Cambodiawhere DARC-negativity is essentially absent (Fig 3), makes
this unlikely. Another possibility is that PvDBP duplications increase the efficiencyof parasite
invasion into erythrocytes carrying other commonDARC genotypes, such as FYA or FYB.
No association betweenPvDBP duplication and these FY genotypes was seen in this study, but
the fact that P. vivax clinical isolates were obtained only from patients with acute malaria epi-
sodesmay confound this analysis. A much larger study that genotypes both theDARC and
PvDBP loci, is conducted where the prevalence of DARC-negativity is high, and includes both
asymptomatic and clinical cases is needed to comprehensively test for association between
PvDBP duplication and DARC genotype. In addition, testing the functional consequences of
PvDBP duplication, through protein binding assays or ex vivo growth assays, are clearly
needed. Since Plasmodium parasites are highly adaptable, understanding how they respond to
human erythrocytevariation will be particularly relevant to studies of naturally-acquired
immunity to PvDBP and the development of any PvDBP-based vaccine.
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